Healthcare interoperability CareEvolution has a strong 15+ year track record in healthcare interoperability and a Health Data Platform that unlocks value from diverse data assets. This suggests sales opportunities with health plans, provider networks, and HIEs seeking advanced data harmonization and integrations.

Clinical research focus The MyDataHelps platform provides end-to-end digital clinical trial capabilities including eConsent, eCOA, EHR data, and automated interventions. This presents upside in patient-centric trials, decentralized studies, and sponsor partnerships looking to streamline data capture and patient engagement.

Recent platform expansion BD[2] Connect launched in 2025 to streamline data collection for bipolar disorder studies, with a partner network. Opportunity exists to cross-sell to additional therapeutic areas and health systems pursuing scalable digital data collection and insights across conditions.

Strategic partnerships Past collaborations with Scripps Research Translational Institute, Vogel Group, Kno2, and DTRA reflect a strong ecosystem approach. This indicates potential for co-sell arrangements, integration partnerships, and access to broader research networks to accelerate trials and data sharing.

Financial and market fit With revenue in the mid six figures to low seven figures and a mid-sized employee base, CareEvolution sits between nimble innovators and larger HIT players. Targeted outreach to mid-market health plans, regional providers, and smaller CROs could yield scalable deployments leveraging their data platform and MyDataHelps capabilities.